search
Back to results

Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis (PBM&KOA-02)

Primary Purpose

Knee Osteoarthritis

Status
Recruiting
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Standard treatment + Active B-Cure laser
Sponsored by
Erika Carmel ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Photobiomodulation, Low-Level Laser Therapy

Eligibility Criteria

50 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Diagnoses of knee osteoarthritis by American College of Rheumatology (ACR)
  2. Kellgren & Lawrence classification 2-3
  3. Knee pain on movement 40 to 90 mm Visual Analog Scale
  4. Knee pain and related functional reduction for the last ≥ 3 months
  5. Agrees not to use NSAIDs throughout the experiment

Exclusion Criteria:

  1. Pregnant or nursing, or with the ability to become pregnant and not using an accepted form of birth control
  2. Other causes of knee-related pain (e.g. hip OA, arterial insufficiency, radiculopathy etc) have been ruled out by physical examinations.
  3. Knee surgery for KOA
  4. Intra-articular steroid injection and/or oral steroid treatment within the last six months
  5. Rheumatoid arthritis
  6. Active malignancy
  7. Uncontrolled diabetes mellitus
  8. Neurological conditions: sciatica, neuropathy, multiple sclerosis
  9. Other chronic pain conditions that may affect results: Fibromyalgia, back pain, hip pain
  10. Has any photobiomodulation (low level laser) device at home or has previously used photobiomodulation for knee pain
  11. Has known dermatological sensitivity to light
  12. Enrolled in any other clinical trial within the last 6 weeks or enrollment in another clinical trial during participation in this trial.

    -

Sites / Locations

  • Holy Family HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Standard treatment + Active B-Cure laser

Arm Description

Subjects from Standard treatment + Active B-Cure laser will receive standard care and in addition will self-treat at home with the B-Cure device.

Outcomes

Primary Outcome Measures

level of pain
Change from baseline in pain score by VAS

Secondary Outcome Measures

Change from baseline in WOMAC score [ time point - 1 month]
The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness. It widely used in clinical studies as primary or secondary outcome.

Full Information

First Posted
April 27, 2022
Last Updated
May 26, 2022
Sponsor
Erika Carmel ltd
Collaborators
Holy Family Hospital, Nazareth, Israel
search

1. Study Identification

Unique Protocol Identification Number
NCT05357703
Brief Title
Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis
Acronym
PBM&KOA-02
Official Title
Evaluation of the Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis: An Open Label, Single-Arm Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 26, 2022 (Anticipated)
Primary Completion Date
May 15, 2023 (Anticipated)
Study Completion Date
August 15, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Erika Carmel ltd
Collaborators
Holy Family Hospital, Nazareth, Israel

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Osteoarthritis is a degenerative disease affecting joint cartilage and its surrounding tissue. It is the leading cause of disability in the elderly. Photobiomodulation (PBM), has been used widely for alleviation of pain, reduction of inflammation, and acceleration of wound healing, and particularly to treat knee osteoarthritis (KOA). The purpose of the current study is to determine if B-Cure laser treatments, applied at home, by the patient or personal caregiver in a real-life situation, can reduce pain and improve functionality in patients with KOA.
Detailed Description
Eligible patients with knee osteoarthritis will receive a B-Cure laser device for self-application at home in addition to standard care. Patients will be invited to the clinic for 3 visits: baseline, 1, and 2 months. Evaluations at the visits will include physical examination, knee range of motion, time up&go test, and patient reported outcomes including subjective pain level by visual analogue scale (VAS), functional and quality of life questionnaires. The study hypothesis is that B-Cure laser treatments, applied, at home, by the patient, can ameliorate KOA related inflammation thereby reducing pain and improving functionality in these patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
Keywords
Photobiomodulation, Low-Level Laser Therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard treatment + Active B-Cure laser
Arm Type
Experimental
Arm Description
Subjects from Standard treatment + Active B-Cure laser will receive standard care and in addition will self-treat at home with the B-Cure device.
Intervention Type
Device
Intervention Name(s)
Standard treatment + Active B-Cure laser
Intervention Description
The B-Cure laser pro is a portal, non-invasive, photobiomodulation device, that emits light in the near infrared (808nm) over an area of 1X4.5 cm2 with power output of 250mW, and energy dose of 5J/minute.
Primary Outcome Measure Information:
Title
level of pain
Description
Change from baseline in pain score by VAS
Time Frame
one month
Secondary Outcome Measure Information:
Title
Change from baseline in WOMAC score [ time point - 1 month]
Description
The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness. It widely used in clinical studies as primary or secondary outcome.
Time Frame
one month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnoses of knee osteoarthritis by American College of Rheumatology (ACR) Kellgren & Lawrence classification 2-3 Knee pain on movement 40 to 90 mm Visual Analog Scale Knee pain and related functional reduction for the last ≥ 3 months Agrees not to use NSAIDs throughout the experiment Exclusion Criteria: Pregnant or nursing, or with the ability to become pregnant and not using an accepted form of birth control Other causes of knee-related pain (e.g. hip OA, arterial insufficiency, radiculopathy etc) have been ruled out by physical examinations. Knee surgery for KOA Intra-articular steroid injection and/or oral steroid treatment within the last six months Rheumatoid arthritis Active malignancy Uncontrolled diabetes mellitus Neurological conditions: sciatica, neuropathy, multiple sclerosis Other chronic pain conditions that may affect results: Fibromyalgia, back pain, hip pain Has any photobiomodulation (low level laser) device at home or has previously used photobiomodulation for knee pain Has known dermatological sensitivity to light Enrolled in any other clinical trial within the last 6 weeks or enrollment in another clinical trial during participation in this trial. -
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jehad Khazen, MD
Phone
+972545600095
Email
khazenjehad@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marwan Hadad, MD
Organizational Affiliation
The Holy Family Hospital, Nazareth, Israel
Official's Role
Principal Investigator
Facility Information:
Facility Name
Holy Family Hospital
City
Nazareth
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jehad Khazen, MD
Phone
972545600095
Email
khazenjehad@gmail.com
First Name & Middle Initial & Last Name & Degree
Maroun Yacoub
Phone
+9720543349738
Ext
+9720543349738
Email
maroun@gd-energies.com

12. IPD Sharing Statement

Learn more about this trial

Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis

We'll reach out to this number within 24 hrs